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Proteins with molecular mass .Mr/ <20 kDa are often poorly separated in 2-D sodium dodecyl sulfate
polyacrylamide gel electrophoresis. In addition, low-Mr proteins may not be readily identified using
peptide mass fingerprinting (PMF) owing to the small number of peptides generated in tryptic digestion.
In this work, we used a 2-D liquid separation method based on chromatofocusing and non-porous
silica reversed-phase high-performance liquid chromatography to purify proteins for matrix-assisted
laser desorption/ionization time-of-flight mass spectrometric (MALDI-TOFMS) analysis and protein
identification. Several proteins were identified using the PMF method where the result was supported
using an accurate Mr value obtained from electrospray ionization TOFMS. However, many proteins were
not identified owing to an insufficient number of peptides observed in the MALDI-TOF experiments. The
small number of peptides detected in MALDI-TOFMS can result from internal fragmentation, the few
arginines in its sequence and incomplete tryptic digestion. MALDI-QTOFMS/MS can be used to identify
many of these proteins. The accurate experimental Mr and pI confirm identification and aid in identifying
post-translational modifications such as truncations and acetylations. In some cases, high-quality MS/MS
data obtained from the MALDI-QTOF spectrometer overcome preferential cleavages and result in protein
identification. Copyright  2004 John Wiley & Sons, Ltd.
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INTRODUCTION
Peptide mass fingerprinting (PMF) has been widely applied
in identifying proteins separated by two-dimensional (2-D)
gel electrophoresis or other multi-dimensional chromato-
graphic methods.1 In this method, proteins are enzymatically
digested and peptide masses are measured by matrix-
assisted laser desorption/ionization time-of-flight mass
spectrometry (MALDI-TOFMS) and experimental masses
are correlated with proteins in a database using vari-
ous algorithms.2 Some of these algorithms1,3 rank proteins
according to the decreasing number of matching peptides
whereas other methods4 use a probability-based algorithm.
An elegant ranking method proposed by Pappin et al.5 com-
bines the frequency distribution of the matching peptides and
provides a normalized probability related score, MOWSE.
The success of all these methods depends on the number
of experimental masses that match the theoretical masses. A
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larger number of matching peptides result in an improved
search result.
The success of PMF relies on the accuracy of the mass
measurement, the number of peptides matched, the sequence
coverage achieved and the complexity of the protein.
Currently, commercial MALDI-TOF mass spectrometers
with delayed extraction and reflectron capabilities can
easily achieve a mass accuracy of <25 ppm with internal
calibration. However, the number of peptides produced
by enzymatic digestion is size or molecular mass Mr
dependent. In general, proteins with high Mr generate more
peptides than those of low Mr. However, not all peptides that
result from digestion can be detected in MALDI-TOFMS. In
most MALDI-TOF instruments there is a useful m/z range of
700–4000, where below 700 the signals are masked by matrix
peaks and above 4000 monoisotopic resolution is often not
achieved. The number of peptides observed is also affected by
the MALDI process. Usually the lysine-terminated peptides
result in a lower signal compared with arginine-terminated
peptides6 owing to the lower proton affinity in the gas
phase,7 where many of these peptides remain undetected.
Modifications, such as phosphorylation and glycosylation,
also decrease the MALDI efficiency. Also, there is sample loss
due to sample preparation, especially during in-gel digestion
in 2-D gel separated proteins so that the number of peptides
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observed is considerably smaller than that expected. As a
result, there may not be a sufficient number of peptides
detected for unambiguous protein identification with the
PMF method, especially for small proteins with Mr < 20 kDa.
Efforts to improve the results from PMF include
increased mass accuracy,8 sequence information obtained
from isotopically labeled peptides,9 – 12 specificity gained
using different enzymatic digestions13 and increased effi-
ciency in MALDI by converting lysine-terminated peptides
to arginine-terminated peptides through a guanidination
reaction.14,15 These steps require chemical modification
or high-accuracy mass spectrometers. An alternative to
PMF in protein identification is tandem mass spectrome-
try (MS/MS). The advantage of the method is that partial
sequence of a single peptide is often adequate for high-
confidence protein identification.
In this study, low-mass proteins were purified from
breast cancer cell whole cell lysates by 2-D liquid-phase
separation. Protein identification for low-Mr proteins was
compared using PMF, modified PMF and the MALDI-QTOF
method. The MALDI-QTOF technique proved to be the most
effective method for identifying low-mass proteins when
coupled with the precise Mr obtained for intact proteins
from the liquid-phase separations. The accurate Mr confirms
the protein identification achieved by using the MS/MS
method. In many cases, the Mr information is necessary for
correct protein identification, especially in human cells in
which there may be several modified isoforms of a protein
present and where there is often sequence homology between
proteins. Nevertheless, the use of all these techniques aids in
identification in these often modified human proteins.
EXPERIMENTAL
MCF10CA1d.cl1 cell preparation and lysis
Fully malignant human breast cancer cells, MCF10CAld
clone 1 (CA1d) cells,16 were grown in monolayer on
plastic in DMEM/F12 medium supplemented with 5%
horse serum, 10 mM HEPES (N-2-hydroxyethylpiperazine-
N0-2-ethanesulfonic acid). Harvesting was performed in the
log phase (¾75–80% confluence). The cells were gently
washed with sterile PBS buffer before they were scraped
with a rubber policeman and stored at 80 °C, after the
growth medium was aspirated.
A 1.0 ml volume of lysis buffer containing 6 M urea,
2 M thiourea, 0.5% (w/v) n-octyl ˇ-D-glucopyranoside (OG),
50 mM dithiothreitol (DTT), 2 mM tris(2-carboxyethyl)phos-
phine (TCEP), 1 µl of protease inhibitor (Sigma, St. Louis,
MO, USA) and 10% (v/v) glycerol was added to cells prior
to vortex mixing for 2 min. The mixture was then left at
room temperature for 1 h. In order to eliminate cell debris,
sample and buffer mixture were centrifuged at 20 000 g
for 20 min. The supernatant was collected and the protein
content was determined using a Bradford-based assay (Bio-
Rad, Hercules, CA, USA).
Chromatofocusing (CF)
As described in previous work,17 lysis buffer in the whole
cell lysate was replaced by the start buffer, which contained
25 mM bis–tris propane (Sigma) and 6 M urea. The pH
was adjusted to 7.4 with saturated imminodiacetic acid
(Sigma) using a PD-10 (Amersham Pharmacia, Piscataway,
NJ, USA) according to the manual prior to the sample
loading. About 7 mg of protein extracted from CAld cells
was loaded on to the CF column followed by elution at
0.2 ml min1 using as elution buffer a mixture of 10% (v/v)
PolyBuffer 74 (Amersham Pharmacia) and 6 M urea with a
pH of 4.0. Saturated imminodiacetic acid was applied for
pH adjustment if necessary. On-line pH measurement was
performed off-column before fraction collection using a pH
electrode (Lazar Research, Los Angeles, CA, USA) and the
separation was monitored at 280 nm using a Beckman Model
126 UV detector (Beckman-Coulter, Fullerton, CA, USA).
Eluate from CF separation was collected from pH 7.4–4.2 at
0.2 pH unit intervals. The collection process was controlled
using software written in-house. All fractions collected were
stored in a dry-ice box after collection. Samples were stored




The NPS RP-HPLC separation was performed at a flow-rate
of 0.5 ml min1 on an ODS IIIE column (33 ð 4.6 mm i.d.)
packed with 1.5 µm non-porous silica beads derivatized with
C18 (Eprogen, Darien, IL, USA). Each CF fraction contained
more than 50 µg of protein, all of which was loaded on
the NPS RP column. During separation, the column was
maintained at 65 °C with a Timberline (Boulder, CO, USA)
column heater in order to improve the resolution and speed
of the separation. Trifluoroacetic acid (TFA) (0.1% (v/v))
was added to both mobile phase A (deionized water) and
mobile phase B (acetonitrile). The gradient profile used was
as follows: (1) 5 to 15% B in 1 min; (2) 15 to 25% B in 2 min;
(3) 25 to 31% B in 3 min; (4) 31 to 41% B in 10 min; (5) 41
to 47% B in 3 min; (6) 47 to 67% B in 4 min; (7) 67 to
100% B in 1 min; (8) 100% B for 2 min; (9) 100 to 5% B in
1 min. The acetonitrile was 99.93% HPLC grade (Sigma) and
the TFA was taken from 1 ml sealed ampules (Sigma). The
HPLC system was a Beckman Model 127 and the separation
was monitored at 214 nm using a Model 166 detector. The
proteins separated by NPS HPLC were collected in 1.5 ml
tubes using a Beckman SC-100 fraction collector controlled
by in-house software. Purified samples were stored in dry-ice
after collection.
NPS RP-HPLC/electrospray ionization (ESI)
TOFMS
In order to obtain the Mr for intact proteins, the CF
fraction with the same pH value from another CF separation
was reseparated by NPS RP-HPLC where the eluate from
NPS RP-HPLC was monitored on-line using ESI-TOFMS
(LCT, Micromass, Manchester, UK). The separation was
performed under the same conditions as in the previous
section. However, in addition to 0.1% TFA, 0.3% formic
acid (Sigma) was added to both mobile phases to improve
the ESI efficiency. The eluent was introduced into the ESI-
TOF system at a flow-rate of 200 µl min1. The capillary
voltage for electrospray was set at 3200 V, sample cone at
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40 V, extraction cone at 3 V and reflection lens at 750 V.
Desolvation was accelerated by maintaining the desolvation
temperature at 300 °C and the source temperature at 120 °C.
The nitrogen gas flow was controlled at 650 l h1. During the
separation, one mass spectrum was acquired per second. The
intact molecular mass value was obtained by deconvoluting
the combined ESI spectra of the protein with MaxEnt 1
software (Micromass).
Peptide preparation for MS analysis
Prior to tryptic digestion, purified proteins were dried down
to 20 µl using a CentriVap concentrator (Labconco, Kansas
City, MO, USA) followed by the addition of 20 µl of 100 mM
ammonium bicarbonate (Sigma) to adjust the solution pH
to ¾7.8. A 0.5 µg amount of L-1-tosylamido-2-phenylethyl
chloromethyl ketone (TPCK) modified sequencing grade
trypsin (Promega, Madison, WI, USA) was added prior to
vortex mixing. The mixture was stored in a warm room with
a controlled temperature of 37 °C for 24 h where the samples
were shielded from light. After digestion had been halted
by adding 1 µl of 10% (v/v) TFA, the tryptic digest mixture
was concentrated to 5 µl using a ZipTip (Millipore, Billerica,
MA, USA). In order to prevent methionine oxidation, light
exposure was minimized by storing the peptide mixture in a
dark-box before and after concentration.
MALDI-TOFMS
Sample spotting was performed by layering 1 µl of matrix on
top of 1 µl of sample. The spot was allowed to dry in air but
without light exposure. The MALDI matrix was prepared
by diluting saturated ˛-cyano hydroxy cinnamic acid (˛-
CHCA) (Sigma) solution made in 50% (v/v) acetonitrile and
1% (v/v) TFA with the same solution in a 1 : 4 (v/v) ratio.
Internal standards were prepared as 1 mg ml1 angiotensin
I, ACTH 1–17 and ACTH 18–39 (Sigma) and were further
diluted 100-fold with deionized water. Volumes of 13, 21 and
25 µl were taken from each of the diluted standard solutions
and mixed with matrix to produce 1 ml of solution containing
50 fmol of each standard per spot.
Peptide masses were measured on a Micromass Tof-
Spec2E system (Micromass/Waters, Milford, MA, USA)
with delayed extraction in the reflectron mode using
a nitrogen laser (337 nm). Peptide mass spectra were
internally calibrated using the three peaks from the
internal standards resulting in a mass accuracy of
50 ppm or less. The calibrated spectra were processed
using PeptideAuto (Micromass MassLynx application) to
obtain experimental masses that were submitted to MS-
Fit (http://prospector.ucsf.edu/ucsfhtml4.0/msfit.htm) to
search the SwissProt database for protein identity. The
following parameters were used for database searching: max-
imum number of two missed cleavages, unmodified cysteine,
Homo sapiens for the species, no restriction on the pH range,
monoisotopic mass. In terms of modification, acetylation was
allowed. However, only when the methionine was oxidized
was ‘methionine oxidation’ included in the database search.
MALDI plate light exposure
Following preparation and analysis under shielded condi-
tions, MALDI target plates were exposed to direct sunlight
for ¾20 h for 3 days by placing them on a sunny windowsill.
After the light exposure, a second MALDI-TOF spectrum was
acquired. For comparison, ACTH 1–17 standard was spotted
on the MALDI plate and MALDI-TOF spectra were acquired
before and after the storage for 3 days in a box shielded
from light. Oxidation was not induced under these condi-
tions. No additional steps were required to study methionine
oxidation.
MALDI-QTOF
After analyzing the MALDI-TOF data, the same MALDI
plate was reanalyzed using a Micromass MALDI Q-TOF
Ultima system (Micromass/Waters) for selected peptides.
According to the MALDI-TOF data, three peptides were
selected from each spot for fragmentation. For parent ions
smaller than 900 and larger than 2700 Da, the collision energy
was set for 40 and 160 eV, respectively. Higher collision
energy was applied for parent ions of higher Mr where
the correlation is linear. The tandem mass spectra were
acquired from m/z 50 to 50 C precursor ion. The nitrogen
laser (337 nm) was scanned over each sample spot in a
raster pattern for a total of 1680 s, 560 s for each parent ion.
The parent ion window was set at 5 Da. Spectra of ACTH
1–17 were acquired for 60 s after completing MS/MS on
each sample spot. Product ion calibration was achieved by
applying the lock mass calibration obtained from ACTH
1–17. The calibrated tandem mass spectrum was subtracted,
smoothed and centered before QTOF transformation, a
process that transforms a spectrum with multiply charged
ions into a spectrum of singly charged monoisotopic ions.
Fragment ions were selected from the tandem mass spectrum
manually and searched against SwissProt using MS-Fit and
Mascot for the peptide sequence and methionine oxidation.
RESULTS AND DISCUSSION
Low molecular mass proteins identified by the
PMF method
Low-Mr proteins are not well separated by current tris-
glycine gel electrophoresis method compared with medium-
and large-sized proteins. Partial improvements can be
achieved by using tris-trycine gels.18 However, post-
separation sample loss during procedures for MS analysis by
in-gel digestion or by blotting methods is significant. Keller
et al. reported improved analysis of low-Mr proteins by accu-
mulating proteins from multiple LC separations using a
nanoliter sample handling technique.19 Alternatively, the
2-D liquid separation method using CF followed by NPS
RP-HPLC provides high-resolution separation of low-Mr
proteins. In addition, the sample recovery for small proteins
is often close to 90%. Losses are also minimal in the digestion
process following collection in the liquid phase.
An accurate Mr value for intact proteins provides essen-
tial information that aids protein identification and char-
acterization, such as post-translational modifications.20,21 In
order to obtain the Mr for intact proteins, on-line HPLC was
performed for each of the fractions collected from CF. The
HPLC conditions, such as gradient, column and tempera-
ture, in each LC/MS experiment were the same as those in
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the offline collection, which was monitored by a UV detector
at 214 nm. Hence the retention time of the LC separation
can be used to correlate the Mr obtained from the on-line
HPLC/MS experiments and the protein identity obtained
from the analysis of the tryptic peptides of the collected
protein that elute at the same retention time. Two of the
ESI-TOF spectra acquired using on-line NPS HPLC/MS are
shown in Fig. 1(A) and 1(B). The Mr values of intact proteins
were produced by deconvoluting Fig. 1(A) and 1(B) using
MaxEnt 1 software and are shown in Fig. 1(C) and 1(D). The
intensity of the well-defined multiply-charged peaks suggest
the abundance of these proteins.
Protein digestion was performed using trypsin and a
peptide mass map obtained using MALDI-TOFMS. When
the peptide masses for each of the purified proteins were
submitted to SwissProt using MS-Fit, the first four proteins
in Table 1 were identified. In all cases, ½5 peptides and
more than 34% sequence coverage were achieved with
galectin having the highest sequence coverage of 70%. The
MALDI-TOF spectrum of galectin is shown in Fig. 2. The
identification was based on the suggestion that at least
five matched peptides with mass accuracy within 50 ppm
and sequence coverage of at least 15% are required to
obtain unambiguous identification using the PMF method.22
All identities were confirmed by the Mr values obtained
from the ESI-TOF experiments. The discrepancy between the
experimental and the theoretical Mr values may result from
as yet unidentified post-translational modifications.
Despite the success of PMF in protein identification,
the method still has many limitations. The method relies
on the number of detected peptides where a number of
factors can prevent peptides from being observed. These
may include internal fragmentation, a weak response for
some of the lysine-terminated peptides, non-specific and
incomplete enzymatic digestion and modifications, which
all result in insufficient peptides observed for unambiguous
protein identification using PMF. In Table 1, all identified
proteins have close to 10 theoretical tryptic peptides in the
‘working range’ of MALDI-TOFMS. In contrast, the proteins
that were not identified have a smaller number of theoretical
peptides in the range, where all have 3 peptides recorded. In
the case of ubiquitin, there are only four theoretical peptides
in the range, all of which were detected. Without the intact Mr
value and peptide sequencing information, it still does not
meet the criteria for unambiguous identification with PMF.
Protein identification enhancement with
methionine oxidation as a sequence tag
Improvements in the PMF method have been explored exten-
sively owing to the continuous increase in protein database
size.9 An increase in mass accuracy significantly enhances
PMF search results and eliminates false positives.10,23 A single
mass detected by Fourier transform ion cyclotron resonance
with mass accuracy of 0.1 ppm can achieve unambiguous
identification for yeast proteins with the constraints of cys-
teine, enzyme and Mr of a protein.24,25 Other methods for
enhancing protein identification involve peptide sequence
information from isotope and mass tags. Among them, alky-
lation of cysteine,26 in vitro isotopically labeling of methio-
nine, serine and tyrosine11,27 and in vivo labeling,28 such as
leucine,12 have been studied. Further modifications can be
achieved by guanidination of lysine on the C-terminus of
the tryptic peptides and Edman-type phenylthiocarbamoy-
lation (PTC) of the N-terminus.14,29,30 By converting lysine to
homoarginine, the response of lysine-terminated peptides is
enhanced. As a result, the lysine residues in the sequence are
revealed and the lysine-terminated peptides are observed.

































Figure 1. ESI-TOF spectrum of galectin (A) and thioredoxin (B). Labels on peaks represent the charge state. Their corresponding
deconvoluted spectra are shown in (C) and (D). Numbers represent the molecular mass of intact proteins. 5934 in (D) is a harmonic
peak, an artifact generated during deconvolution using MaxEnt 1 software.
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Galectin (P09382) 14 716/5.3 14 715 13 9 7 70
Stathmin (P16949) 17 303/5.8 17 311 33 10 6 36
Glia maturation factor beta (P17774) 16 713/5.2 16 784 22 9 5 47
ATP synthase D chain, mitochondrial (O75947) 18 360/5.2 18 403 21 10 5 34
Ubiquitin (P02248) 8564/6.6 8564 12 4 4 47
TCTP (P13693) 19 596/4.8 19 607 19 8 3 20
Centrin 2 (P41208) 19 738/4.9 19 807 31 9 3 29
Barrier to autointegration factor (O75531) 10 059/5.8 10 048 12 6 2 40
Cytochrome c oxidase polypeptide VA (P20674) 12 436/5.0 12 443 10 7 2 20
Thioredoxin (Q99757) 18 383/8.5a 11 868 18 9 2 37
40S ribosomal protein S21 (P35265) 9111/8.7 9154 13 5 1 18
ATP synthase coupling factor 6, mitochondrial
precursor (P18859)
12 588/9.5b 8962 13 4 1 25
Cystatin B, human (P04080) 11 140/7.0 11 182 11 6 2 33
Thymosin ˇ10 (P13472) 4894/5.3 4936 9 3 1 32
Ribosomal protein p2 (P05387) 11 665/4.4 11 662 10 6 3 28
Replicatrion protein A3 (P35244) 13 569/5.0 13 425 11 7 2 27
U6 snRNA-associated Sm-like protein LSm7
(Q9UK45)
11 602/5.1 11 606 13 7 1 17
a The theoretical Mr/pI of thioredoxin (mitochondrial) are 18383/8.5, but the truncated form has theoretical values of 11 867/4.9.
b The theoretical Mr/pI of ATP synthase coupling factor 6 (mitochondrial) are 12 588/9.5, but the truncated form has theoretical values
of 8960/5.5.








































































































Figure 2. Galectin 1 MALDI-TOF spectrum.
Improved identification of proteins in PMF can also be
achieved using methionine oxidation as a tag. This can be
induced by a number of different methods, most notably
using hydrogen peroxide or light. Methionine residues
in methionine-containing proteins are not oxidized to
sulfoxide during the 2-D liquid separation. If the methionine-
containing peptides on the MALDI target plate are exposed
to light for 3 days, new peaks due to the methionine oxidation
are observed. The oxidation of methionine to sulfoxide
results in peaks 16 Da higher than the original peak, a mass
tag indicating the presence of methionine residues. As shown
in Fig. 3, doublet peaks 16 Da apart indicate one Met in the
peptide and triplet peaks 16 Da apart indicate two Mets
in the peptide sequence. When the methionine sequence
information was included in the database search, the result
was improved, as suggested by the increase in MOWSE score
as shown in Table 2. TCTP and centrin 2 are identified with
confidence with the support from the experimental Mr for
the intact protein, but not for barrier-to-autointegration factor
and cytochrome c oxidase polypeptide VA because only two
peptides were matched. Another problem for the method
is that it is not broadly applicable since only methionine-
containing peptides contribute to the enhancement.
Identification with MALDI-QTOF
General identification with MALDI-QTOF
Another protein identification method is based on peptide
sequencing. Collision-induced dissociation (CID) amide
bond fragmentation along the length of peptide generates
b- and y-ions, which reveal the peptide sequence. Protein
identification is achieved by searching the protein and
nucleotide databases with product ions recorded in this
experiment.23,31,32 The partial sequence information obtained
from MS/MS has more discriminating power than the PMF
and may allow the identification of proteins based on a
single peptide. The advantage is that small proteins may
be identified if the peptide signal and its fragment signals
are of sufficient intensity. The MALDI-QTOF system used
in this work provides high resolution and the advantage of
sharing the same sample preparation method with MALDI-
TOFMS. A spot analyzed by MALDI-TOF can be reanalyzed
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Figure 3. (A) MALDI-TOF spectrum of TCTP (P13693), GRP78, pyruvate kinase (P14786) and barrier-to-autointegration factor
(O75531) mixtures. Peaks resulting from methionine oxidation were observed in the zoom-in spectra for barrier-to-autointegration
factor (B) and TCTP (C) after light exposure for 3 days; their corresponding spectra prior to light exposure are shown in (D) and
(E), respectively.
by MALDI-QTOF after selecting the peaks that need to
be further analyzed. The quality of MS/MS data obtained
and the effectiveness of using MALDI-QTOF in protein
identification have been reported.33 – 35
Two of the MALDI-QTOF tandem mass spectra for
the singly charged peptides 1429 (DSNNLCLHFNPR) and
1784 (LNLEAINYMAADGDFK) from galectin 1 are shown
in Fig. 4. Both spectra show abundant b- and y-ions and
are rich in sequence information. No dramatic difference
in the abundance of product ions was observed, which
indicates equal probability for amide bond cleavage across
the backbone in CID. In the LNLEAINYMAADGDFK case, as
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Table 2. Database search enhancement with Met oxidation
Database search result
Without Met oxidation With Met oxidation
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Figure 4. MALDI-QTOF tandem mass spectra of tryptic digest peptides from galectin 1. (A) DSNNLCLHFNPR (1429);
(B) LNLEAINYMAADGDFK (1784).
in Fig. 4(B), multiple peaks from y4 to y10 clearly sequenced
NYMAAD. When product ions for each peptide and parent
ion were used to search against SwissProt using MASCOT
and MS-Tag, galectin 1 was unambiguously identified. The
accurate Mr suggests that no modifications occur.
Thioredoxin and 40S ribosomal protein S21 are rela-
tively low-abundance proteins in the breast cancer sample.
Only two peptides were detected in MALDI-TOFMS for
thioredoxin and one for 40S ribosomal protein S21. Never-
theless, they were identified by MS/MS data acquired by
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the MALDI-QTOF spectrometer based on 1751 (FVGIKD-
EDQLEAFLK) and 1796 (MQNDAGEFVDLYVPR C acetyl
N-terminus), respectively. The theoretical Mr and pI values
from the database for thioredoxin are 18 383 and 8.5, respec-
tively, which are significantly higher than the experimental
Mr of 11 868 Da and pI 4.8–5.0. The first 59 amino acids were
truncated when entering mitochondria, so that the accurate
experimental Mr and pI values suggest that it is present in
its mature form. When the truncation is taken into account
and the theoretical Mr and pI are recalculated without the
first 59 amino acids in its sequence, the experimental and the
theoretical values match perfectly. In the case of the 40S ribo-
somal protein S21, the intact Mr obtained also supports the
protein identification and the acetylation at the N-terminus.
Truncated ATP synthase coupling factor 6 has an Mr of 8962,
which only results in four peptides above 700. As in the case
of ubiquitin, it cannot be identified by PMF alone, even if all
four peptides are detected. However, fragmentation of 2081
(QTSGGPVDASSEYQQELER) by QTOF reveals its identity,
which was also confirmed by an accurate experimental Mr.
Internal fragmentation
Internal fragmentation may result in an insufficient num-
ber of peptides for protein identification using PMF owing
to the mismatch of the observed fragment masses with the
theoretical masses in the database. Such internal fragmen-
tation may result from sample preparation or unspecific
digestion. A QTOF tandem mass spectrum of IGENMN-
PDGMVALLDYR, which is an internal fragment of NYQF-
FIGENMNPDGMVALLDYR from TCTP, is shown in Fig. 5.
Various b and y ions were detected. On submitting the
MS/MS data for protein identification without enzyme speci-
fication, TCTP was identified, whereas it remains unmatched
in the PMF method.
Proteins with few arginines in their sequence
In another case, some proteins may contain few arginines
in their sequence. The result is that the number of pep-
tide masses acquired by MALDI-TOFMS is not sufficient
for an unambiguous identification. Cystatin B only has two
arginines present in its sequence, as shown in Fig. 6(A), so
that only one mass was recorded in MALDI-TOFMS. How-
ever, the high-quality QTOF tandem mass spectrum shown
in Fig. 7 clearly reveals the sequence VHVGDEDFVHLR,
which brings cystatin B to the top of the list in a MASCOT
search. The experimental Mr of the intact protein is 42 Da
higher than its theoretical Mr, which indicates acetylation
of the protein. Acetylation is a probable modification at its
N-terminal site, although no further result was obtained to
support the result. On the other hand, thymosin ˇ10 contains
only one arginine in its sequence, as shown in Fig. 6(B).
Its identification was achieved by fragmentation of 1565
(ADKPDMGEIASFDK C acetyl) using the QTOF spectrome-
ter. In an extreme case, thymosin ˇ4 contains no arginine in its
sequence so that only two weak peaks corresponding to two
peptides were recorded. These were not of sufficient intensity
for the MALDI-QTOF experiment, although the abundance
of this protein is high enough for capillary electrophoresis
(CE)/MS and CE/MS/MS analysis for its identification.20
Incomplete tryptic digestion
Other than unspecific tryptic digestion and internal frag-
mentation, there may be multiple miscleavages in tryptic
digestion. When only one miscleavage was allowed in the
database search for the acquired masses from a tryptic digest
of cytochrome c oxidase polypeptide VA, only two pep-
tides, 2664 and 1356 (VIQELRPTLNELGISTPEELGLDK and
NKPDIDAWELR), were matched, where one of the two
peptides has a miscleavage. The sequence of both peptides
1    MMCGAPSATQ  PATAETQHIA  DQVRSQLEEK ENKKFPVFKA  VSFKSQVVAG TNYFIKVHVG  60      A
61  DEDFVHLRVF  QSLPHENKPL  TLSNYQTNKA  KHDELTYF
1    ADKPDMGEIA SFDKAKLKKT ETQEKNTLPT KETIEQEKRS EIS           B
Figure 6. (A) Cystatin B sequence. Two arginines present in its
sequence. (B) Thymosin ˇ10 sequence. Only one arginine
present in its sequence. R residues are underlined.















Figure 5. MALDI-QTOF tandem mass spectrum for 1908 (IGENMNPDGMVALLDYR) from TCTP, which is an internal fragment of
NYQFFIGENMNPDGMVALLDYR (2607).
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Figure 7. MALDI-QTOF tandem mass spectrum of VHVGDEDFVHLR from cystatin B.




































Figure 8. MALDI-QTOF tandem mass spectrum of VIQELRPTLNELGISTPEELGLDKV from cytochrome c oxidase polypeptide VA.
was confirmed by MS/MS experiments. However, when two
miscleavages were allowed, another peptide, 2763 (VIQEL-
RPTLNELGISTPEELGLDKV), which has one R and one K in
its sequence, was recovered. The tandem mass spectrum of
the peptide is shown in Fig. 8. The appearance of 2664 and
2763 at the same time suggests incomplete tryptic digestion
where the two peptides are different and 2763 has a valine
at its C-terminus. The incomplete digestion is due to the
slow digestion rate of trypsin when P or D is adjacent to
R and K. However, even when incomplete digestion results
in unassigned peptides, QTOFMS can still recover correct
protein identification.
Preferential cleavage
One problem with the MALDI-based MS/MS technique is
that the dissociation of protonated peptide is not always
evenly distributed across the peptide backbone. The singly
charged peptide generated in MALDI favors cleavages
C-terminal to aspartic acid (D) and glutamic acid (E) if the C-
terminus is arginine.36,37 This is clearly shown in Figs 5 and 9,
where y2 and y9 of IGENMNPDGMVALLDYR and y3, y7 and
y15 of GFDPLLNLVLDGTIEYMR dominate, respectively.
The disadvantage is that a contiguous series of backbone
cleavage sequence ions may not be obtained in a MALDI
tandem mass spectrum. Given that current popular search
algorithms are based on the assumption that amide bonds are
cleaved with the same probability across the backbone of the
protonated peptide,38 preferential cleavage may jeopardize
unambiguous protein identification. However, the high-
quality tandem mass spectra obtained from the QTOF
spectrometer still provided sufficient sequence information
to identify U6 snRNA-associated Sm-like protein LSm7 and
TCTP.
Copyright  2004 John Wiley & Sons, Ltd. J. Mass Spectrom. 2004; 39: 770–780
Identification of low molecular weight proteins 779
643.4551.4






















Figure 9. MALDI-QTOF tandem mass spectrum for 2066 (GFDPLLNLVLDGTIEYMR) from U6 snRNA-associated Sm-like
protein LSm7.
CONCLUSION
Low-Mr proteins were separated from breast cancer cells
using 2-D liquid separations. When the PMF method was
used for identification, four proteins with Mr < 20 kDa
were unambiguously identified. The identification was
supported by an accurate Mr value obtained from ESI-
TOFMS. However, other proteins remain unidentified owing
to an insufficient number of proteins detected by MALDI-
TOFMS. An enhancement of PMF can be achieved by
including sequence information obtained from on-target
light-induced methionine oxidation, but many proteins still
remain unidentified. Significant improvements in protein
identification were obtained when MALDI-QTOFMS was
applied for analyzing the proteins with an insufficient
number of peptides for PMF. The method achieves protein
identification for proteins, which were not identified in
PMF owing to internal fragmentation, few arginines in the
sequence and incomplete tryptic digestion. In some cases,
high-quality MS/MS data obtained from MALDI-QTOFMS
overcome preferential cleavages and result in unambiguous
protein identification when combined together with the Mr
value of the intact protein. The accurate Mr confirms the
protein identification achieved by using the MS/MS and
in many cases the Mr information is necessary for correct
protein identification, especially for modified forms.
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